Doctors in the Upstate are touting the potential of a cancer immunology vaccine currently undergoing clinical trials. The vaccine, developed by Dr. Thomas Wagner and his company Orbis Health Solutions, has shown promising results in treating cancer patients and could potentially revolutionize cancer treatment.

In the latest clinical trial, the vaccine demonstrated a remarkable impact on patients with stage 4 melanoma, a particularly aggressive form of skin cancer. What is even more staggering is that the vaccine had minimal side effects, making it an attractive option for patients seeking alternative treatments.

Dr. Wagner enthusiastically shared the trial outcomes, stating that patients with stage 4 melanoma have a survival rate of less than 20% after two years. However, in the patients treated with the vaccine, an astonishing 90-95% showed no signs of the disease even after three years.

The vaccine operates by utilizing a unique approach. Doctors extract a sample of the tumor, which is then encapsulated within a molecule that triggers the body's immune response. As cancer cells are essentially mutated versions of the body's own cells, the immune system does not recognize them as a threat. This vaccine, however, trains the immune system to identify and fight off the cancer cells effectively.

Dr. Wagner is buoyed by the success of the vaccine, which he claims has already helped hundreds of patients. He highlighted the inspiring case of a woman from Greenville who has defied the odds. Diagnosed with stage 4 melanoma 23 years ago and given a mere three months to live, she is still alive and thriving today thanks to the vaccine.

Despite these promising results, Dr. Wagner cautioned that the vaccine will need to undergo further scrutiny before it can be made available to the public. It will need to successfully complete a Phase 3 clinical trial, a rigorous process overseen by the U.S. Food and Drug Administration (FDA). This final phase can be both expensive and time-consuming.

However, Dr. Wagner remains optimistic about the future of cancer treatment. He believes that a combination of early detection and immunotherapy, such as the cancer immunology vaccine, holds the key to curing cancer in the short term.

The groundbreaking research and clinical trials taking place in the Upstate are shining a light on the potential of immunotherapy as a game-changer in the fight against cancer. As the scientific community eagerly awaits the completion of the Phase 3 trial, patients and doctors alike anticipate a future where cancer can be conquered with greater success and fewer side effects.